Skip to main content
. 2018 Sep 19;9(5):880–897. doi: 10.1002/jcsm.12316

Table 3.

Frequency and incidence of treatment‐emergent adverse events classified by Medra System Organ Class (SOC)

Placebo (N = 7) 150 M PLX‐PAD (N = 7) 300 M PLX‐PAD (N = 6)
No. event No. subj. % of subj. No. event No. subj. % of subj. no. event No. subj. % of subj.
System Organ Class Preferred term 42 6 85.7 45 7 100.0 28 6 100.0
‐ALL ‐ALL
Ear and labyrinth disorders ‐ALL 1 1 14.3 1 1 14.3 2 2 33.3
Vertigo 1 1 14.3 1 1 14.3 1 1 16.7
Vertigo positional . . . . . . 1 1 16.7
Eye disorders ‐ALL 1 1 14.3 1 1 14.3 . . .
Photophobia 1 1 14.3 . . . . . .
Vision blurred . . . 1 1 14.3 . . .
Gastrointestinal disorders ‐ALL 5 4 57.1 3 3 42.9 3 2 33.3
Breath odour 1 1 14.3 2 2 28.6 1 1 16.7
Constipation 1 1 14.3 . . . . . .
Flatulence 1 1 14.3 . . . . . .
Nausea 2 2 28.6 1 1 14.3 1 1 16.7
Vomiting . . . . . . 1 1 16.7
General disorders and administration site conditions ‐ALL 3 3 42.9 2 2 28.6 2 2 33.3
Fatigue 1 1 14.3 1 1 14.3 1 1 16.7
Local swelling 1 1 14.3 . . . . . .
Pyrexia 1 1 14.3 . . . . . .
Pain . . . 1 1 14.3 . . .
Discomfort . . . . . . 1 1 16.7
Immune system disorders ‐ALL 1 1 14.3 . . . . . .
Seasonal allergy 1 1 14.3 . . . . . .
Infections and infestations ‐ALL 1 1 14.3 . . . . . .
Gastrointestinal infection 1 1 14.3 . . . . . .
Injury, poisoning and procedural complications ‐ALL 14 4 57.1 18 7 100.0 9 6 100.0
Anaemia post‐operative 3 3 42.9 1 1 14.3 . . .
Post‐procedural haemorrhage 1 1 14.3 . . . . . .
Post‐procedural swelling 4 2 28.6 3 3 42.9 4 3 50.0
Procedural hypotension 2 2 28.6 3 2 28.6 1 1 16.7
Procedural pain 4 3 42.9 7 5 71.4 3 3 50.0
Fall . . . 1 1 14.3 . . .
Muscle strain . . . 1 1 14.3 . . .
Suture‐related complication . . . 2 2 28.6 . . .
Procedural hypertension . . . . . . 1 1 16.7
Musculoskeletal and connective tissue disorders ‐ALL 3 2 28.6 10 4 57.1 4 3 50.0
Arthralgia 1 1 14.3 . . . 2 1 16.7
Femur fracture 1 1 14.3 1 1 14.3 . . .
Myalgia 1 1 14.3 . . . . . .
Extraskeletal ossification . . . 1 1 14.3 . . .
Humerus fracture . . . 1 1 14.3 . . .
Joint swelling . . . 1 1 14.3 . . .
Muscle spasms . . . 3 2 28.6 1 1 16.7
Muscle tightness . . . 1 1 14.3 . . .
Pain in extremity . . . 1 1 14.3 . . .
Sacroiliitis . . . 1 1 14.3 . . .
Limb asymmetry . . . . . . 1 1 16.7
Nervous system disorders ‐ALL 4 4 57.1 7 3 42.9 1 1 16.7
Dizziness postural 1 1 14.3 . . . . . .
Nerve compression 1 1 14.3 . . . . . .
Paraesthesia 1 1 14.3 3 2 28.6 . . .
Somnolence 1 1 14.3 . . . . . .
Carpal tunnel syndrome . . . 1 1 14.3 . . .
Headache . . . 1 1 14.3 . . .
Hypoaesthesia . . . 1 1 14.3 1 1 16.7
Restless legs syndrome . . . 1 1 14.3 . . .
Psychiatric disorders ‐ALL 2 2 28.6 1 1 14.3 2 2 33.3
Anxiety 1 1 14.3 . . . . . .
Restlessness 1 1 14.3 1 1 14.3 1 1 16.7
Insomnia . . . . . . 1 1 16.7
Renal and urinary disorders ‐ALL 2 1 14.3 1 1 14.3 . . .
Urethral cyst 2 1 14.3 . . . . . .
Urinary tract infection . . . 1 1 14.3 . . .
Respiratory, thoracic, and mediastinal disorders ‐ALL 3 3 42.9 . . . 2 2 33.3
Cough 1 1 14.3 . . . . . .
Nasopharyngitis 2 2 28.6 . . . 2 2 33.3
Skin and subcutaneous tissue disorders ‐ALL 2 2 28.6 . . . 3 3 50.0
Alopecia 2 2 28.6 . . . . . .
Erythema . . . . . . 1 1 16.7
Heat rash . . . . . . 1 1 16.7
Pruritus . . . . . . 1 1 16.7
Reproductive system and breast disorders ‐ALL . . . 1 1 14.3 . . .
Breast pain . . . 1 1 14.3 . . .